Abstract
BackgroundNectin-4 is overexpressed in multiple solid tumors with high unmet medical need, such as urothelial carcinoma (UC), esophageal cancer, non-small cell lung cancer, or triple-negative breast cancer. Enfortumab vedotin (EV),...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
